“Stanford appoints new leader to expand impact in early drug development”

Dr. Pamela Munster, will assume a faculty appointment as a Professor of Medicine in the Division of Oncology on August 1, 2026.”

Read more 

• The following Division of Oncology Faculty were named Fellow of the American Society of Clinical Oncology (FASCO):
  
  2026:
  • Ranjana H. Advani, MD, FASCO
  • Allison Betof, MD, PhD, FASCO
  • Ali Raza Khaki, MD, MS, FASCO

• 2025:
  • Kavitha Ramchandran, MD, FASCO
  • Pauline Funchain, MD, FASCO

“The FASCO designation honors members for their extraordinary volunteer service, engagement, and dedication to the American Society of Clinical Oncology and the Association for Clinical Oncology (collectively ASCO).”

Other notable recognitions:

• Pauline Funchain, MD, FASCO Stanford Cancer Institute associate director for training and education, served as a Featured Voice at this year's meeting.
• Jacqueline Aredo, MD was named to ASCO's 2026 Class of 40 Under 40 in Cancer.
• Hematology-oncology fellows Patrick Bolan, MD, Alanna Kaplan, MD, PhD, and Alexander Salter, MD, PhD, received a Conquer Cancer Foundation Young Investigator Awards.

Read more

Dr. Curtis Chong Receives the 2026 Arthur L. Bloomfield Award for Excellence in Clinical Teachin

“This award was established in recognition of Dr. Arthur L. Bloomfield’s reputation as a gifted teacher, and eligible recipients are individuals from the Stanford faculty who excel as teachers in clinical medicine. The Award recipients are recognized at the School of Medicine Commencement Ceremony.”

DoM Q&A with Dr. Corsello

Teaching Pancreatic Cancer Cells to Self-Destruct

“Pancreatic cancer remains one of the most difficult cancers to treat. In the United States alone, the disease claims more than 50,000 lives each year, a reality that physician-scientist Steven Corsello, MD, sees up close in his work as an oncologist.”

Read more 

Welcome New Faculty

“Vivek Subbiah, MD, has been appointed as the inaugural associate director for drug development and precision oncology at the Stanford Cancer Institute, with a planned start date in spring 2026. In this role, he will lead the Early Drug Development Program to expand access to innovative treatments for Stanford cancer patients through phase 1 trials, targeted therapeutics, and study designs that match patients to treatments based on biological markers.”

Read more

Christina Curtis named Fellow of the American Association for Cancer Research (AACR)

Christina Curtis, PhD, MSc, Professor of Medicine, Genetics and Biomedical Data Science, was elected Fellows of the AACR Academy Class of 2026 “for transformative discoveries applying computational and systems biology to breast and gastrointestinal cancers, integrating multi-omic and phylogenetic frameworks to uncover copy number-driven subgroups, resolve tumor evolutionary trajectories, and develop biomarkers to refine risk stratification and therapeutic response prediction.”

Read more

Dr. Goyal Featured in Stanford Cancer Institute News

“Uniting compassion and breakthrough discoveries”

Lipika Goyal, MD, Associate Professor of Medicine, Oncology was featured in a recent article chornicling the care and treatment of fellow Stanford physician Paul Yock, MD, Martha Meier Weiland Professor in the School of Medicine and Professor of Bioengineering, Emeritus. 

Read more

Congratulations Drs. Patel & Corsello

Dr. Manali Patel was recently honored with the VHA All-Employee Innovation Program (VA Palo Alto), a national recognition that celebrates creative solutions designed to enhance Veteran care for her work on

"Improving Symptom Care for Veterans with Cancer."

Dr. Steven Corsello named one of the 2026 NextGen Stars. He will be presenting "Discovery of TRIM21 molecular glues that drive potent anti-tumor efficacy via nuclear pore complex degradation" at the upcoming AACR Annual Meeting in

Welcome New Faculty

Please join us in welcoming our newest faculty member Maximillian "Max" Julvé, MD, Clinical Assistant Professor, who officially started on January 16!

Dr. Julvé is a clinical investigator specializing in melanoma, immuno-oncology, and solid tumor adoptive cellular therapy (ACT). He joins us after completing training at The Royal College of Physicians, The Institute of Cancer Research, London and The Royal Marsden Hospital, London.